The session highlighted that: Weight loss typically plateaus after an initial period Weight regain commonly occurs after medication discontinuation Repeated cycles of loss and regain raise medical and psychological concerns Focusing solely on short-term weight loss obscures longer-term patterns and may contribute to harm, particularly for individuals vulnerable to eating disorders
The growing obesity medication landscape includes GLP-1 agonists like Wegovy and Ozempic, combination drugs like Contrave and Qsymia, and newer drugs like Zepbound, which can lead to up to 20% weight loss
Learn more about our solutions here: To view or add a comment, sign in Introducing Metolazone Tablets 2.5 mg & 5 mg Metolazone, a potent thiazide-like diuretic, is a valuable tool in managing hypertension and edema, especially in cases of diuretic resistance (often paired with a loop diuretic)
This is particularly important for women using GLP-1 medications, as these factors can also influence the medication's effectiveness